Advanced excipients could emerge as India’s next big pharma advantage
When the Central Drugs Standard Control Organization (CDSCO) revised Good Manufacturing Practice norms under Schedule M in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Venus Medicine Research Centre
Driving innovation in India’s pharma R&D through cell and gene therapy
Saransh Chaudhary, President, Global Critical Care, Venus Remedies and CEO, Venus Medicine Research Centre highlights how…
Strengthening drug security through a resilient and affordable pharmaceutical supply chain
Saransh Chaudhary, President, Global Critical Care, Venus Remedies, and CEO, Venus Medicine Research Centre explains strategies to…
Venus Remedies gets GMP certification from Libya
This GMP certification has added to the company's portfolio of international approvals from 25 regulators
Expectations from Budget 2024: Govt must prioritise funds for digital integration in pharma supply…
Saransh Chaudhary, President, Global Critical Care, Venus Remedies, and CEO, Venus Medicine Research Centre (VMRC) also states…
Venus Remedies launches Elores in Ecuador
Elores, an antibiotic formulation has been developed to combat multi-drug-resistant infections
DSIR renews recognition for Venus Remedies’ R&D unit
The company invested 3.53 per cent of its total sales in R&D, from which it has generated 5.25 per cent of its total revenue,…
Venus Remedies bags Indian patent for Vancoplus
Vancoplus projected to cater to a market of Rs 214 crore in India by 2018-19